<DOC>
	<DOCNO>NCT02873910</DOCNO>
	<brief_summary>The purpose study evaluate benefit tolerability IQP-AS-119 reduction susceptibility infection complaint extreme physical stress ( participation marathon ) .</brief_summary>
	<brief_title>Influence IQPAS-119 Post-Marathon Susceptibility Infections Others</brief_title>
	<detailed_description />
	<mesh_term>Disease Susceptibility</mesh_term>
	<criteria>1 . Caucasian male female , 1865 year age , resident Berlin Brandenburg 2 . Body mass index ( BMI ) 18.526.0 kg/m2 3 . Registered runner 43rd BMW Berlin Marathon 2016 4 . History least 2 successful finish marathon ( personal record 35.5h within last 5 year ) 5 . History postexercise susceptibility infection ( e.g . upper respiratory tract symptom ) and/or health condition ( infection , stress complaint ) strenuous exercise ( eg . marathon , halfmarathon , bicycle race , triathlons , heavy training load ) within last 5 year ( distinctly document screening ) 6 . Readiness comply study procedure , particular : Consumption investigational product ( IP ) entire treatment period study Maintaining habitual diet , exception consumption maximal 2 garlic clove per week Adapt premarathon training / physical activity generally accept proven individually successful training plan Adapt postmarathon train / physical activity generally accept proven individually successful recovery plan Filling diaries questionnaires 7 . Readiness ensure generally prove individually successful optimal food intake rehydration , , marathon . 8 . Nonsmoker / smoke cessation last ≥12 month prior screen 9 . Regular sleeping pattern ( suspicion sleep disorder ) three month prior screen 10 . Stable concomitant , permit medication ( ) least last 2 week prior screen study 11 . Women childbearing potential : 1. negative pregnancy test ( Beta human chorionic gonadotropin ( ßHCG ) urine ) screen 2. commitment use reliable contraception method entire study Participation base upon write informed consent form ( ICF ) participant follow write oral information investigator regard nature , purpose , consequence possible risk clinical study . 1 . Known sensitivity ingredient IP 2 . Additional strenuous exercise/activity regular occupational load , complete training run / exercise prior marathon . Additional strenuous exercise/activity regular occupational load recovery exercise load marathon 3 . History severe cardiovascular disease collapse run event ( half marathon , marathon etc . ) and/or train 4 . Hypertension ( systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg ) 5 . Any abnormality observe screening exercise ECG pointing increase cardiovascular risk ( alternatively : abnormality result exercise ECG perform last 6 week prior screen point increase cardiovascular risk ) 6 . Any chronic disease affect upper respiratory tract lung , eg . asthma bronchial , chronic obstructive pulmonary disease , earsnosethroat ( ENT ) infection 7 . Acute infection ENT upper respiratory tract ( URT ) within last month prior screen 8 . Any nasal abnormality : 1 . History nasal reconstructive surgery 2 . Severe nasal septum deviation condition could cause nasal obstruction 3 . Presence nasal ulcer nasal polyps 9 . Active organ systemic disease include severe cardiovascular disease , diabetes mellitus , renal liver disorder 10 . Known congenital acquire immunodeficiency disease ( e.g . HIV infection ) 11 . Known bleed disorder bleed ulcer , haemophilia 12 . Vaccination influenza within 3 month prior screen ; vaccination plan study 13 . Anticoagulants warfarin 14 . Systemic analgesic ( paracetamol 2000mg/day ibuprofen max . 800 mg/day , medically indicate prescribed physician ) , antibiotic ( unless medically indicate prescribed physician ) decongestant nose drop / spray ( except isotonic sea water , medically indicate prescribed physician ) study 15 . Use medication supplement influence immune function ( e.g . antihistamine , systemic corticosteroid , immunesuppressants ) , physical performance , per investigator 's judgement , study 16 . Use dope substance list `` World AntiDoping Agency '' present past , unless prescribe physician ' '' therapeutic use exemption '' , per investigator 's judgement 17 . Any use food supplement contain vitamin , mineral , trace element , per investigator 's judgement , study 18 . Alcohol abuse ( men : ≥21 units/week , woman : ≥14 units/ week ; 1 unit equal approximately 250 mL beer , 100 mL wine 35 mL spirit ) 19 . Women childbearing potential : pregnant breastfeed 20 . Participation study within last month prior screen study 21 . Any clinically significant condition investigator 's opinion could interfere result study safety subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>